Catalyst
Slingshot members are tracking this event:
Cidara recieves Orphan Drug Designation for novel Echinocandin, CU101 IV, in Candidemia and Invasive Candidiasis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CDTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 10, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fungal Infections, Cd101 Iv, Cu101 Iv, Candidemia, Invasive Candidiasis, Orphan Drug Designation, Mad Clinical Trial, Echinocandins
